These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126 [TBL] [Abstract][Full Text] [Related]
28. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer. Dinniwell R; Lock M; Pintilie M; Fyles A; Laframboise S; Depetrillo D; Levin W; Manchul L; Murphy J; Oza A; Rosen B; Sturgeon J; Milosevic M Int J Radiat Oncol Biol Phys; 2005 May; 62(1):104-10. PubMed ID: 15850909 [TBL] [Abstract][Full Text] [Related]
29. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases. Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230 [TBL] [Abstract][Full Text] [Related]
30. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Tchabo NE; McCloskey S; Mashtare TL; Andrews C; Singh AK; Mhawech-Fauceglia P; Odunsi K; Lele S; Jaggernauth W Gynecol Oncol; 2009 Nov; 115(2):249-56. PubMed ID: 19692115 [TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. Steed H; Oza AM; Murphy J; Laframboise S; Lockwood G; DE Petrillo D; Sturgeon J; Rosen B Int J Gynecol Cancer; 2006; 16 Suppl 1():47-53. PubMed ID: 16515567 [TBL] [Abstract][Full Text] [Related]
32. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948 [TBL] [Abstract][Full Text] [Related]
33. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study. Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568 [TBL] [Abstract][Full Text] [Related]
34. A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes. Mabuchi S; Isohashi F; Yokoi T; Takemura M; Yoshino K; Shiki Y; Ito K; Enomoto T; Ogawa K; Kimura T Gynecol Oncol; 2016 May; 141(2):240-246. PubMed ID: 26883141 [TBL] [Abstract][Full Text] [Related]
35. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study. Mahdi H; Rose PG; Elshaikh MA; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; DeBenardo R Gynecol Oncol; 2015 Mar; 136(3):529-33. PubMed ID: 25575483 [TBL] [Abstract][Full Text] [Related]
37. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947 [TBL] [Abstract][Full Text] [Related]
38. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926 [TBL] [Abstract][Full Text] [Related]
39. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Ayhan A; Taskiran C; Yigit-Celik N; Bozdag G; Gultekin M; Usubutun A; Guler N; Yuce K Int J Gynecol Cancer; 2006; 16(2):484-9. PubMed ID: 16681715 [TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy]. Xue DB; Ding LJ; Xia AL; Chen D; Xia HP; Teng XD; Xu ST; Zhang SJ; Ren XC Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):671-4. PubMed ID: 21176532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]